Novel physiologically active substances
Details for Australian Patent Application No. 2002230128 (hide)
International Classifications
Event Publications
20 February 2003 Application Open to Public Inspection
Published as AU-B-2002230128
19 April 2007 Application Accepted
Published as AU-B-2002230128
31 May 2007 Assignment before Grant
Eisai Co., Ltd.; Mercian Corporation The application has been assigned to Mercian Corporation; Eisai R&D Management Co., Ltd.
16 August 2007 Standard Patent Sealed
8 March 2012 Assignment Registered
Eisai R&D Management Co., Ltd.; Mercian Corporation The patent has been assigned to Eisai R&D Management Co., Ltd.; MicroBiopharm Japan Co., Ltd. Assignments Registered
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002230129-NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF
2002230127-HYBRIDIZED ARRAY ANALYSIS AIDING METHOD AND ANALYSIS AIDING DEVICE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser